1) Perifolliculitis capitis abscedens et suffodiens, currently called dissecting cellulitis of the scalp, is classifi ed as primary scarring alopecia since the 2000 consensus statement. Recent publications do not associate this condition with fungal colonization. 2 The 2013 paper “What’s new in cicatricial alopecia?” indicates an infl ammatory process that attacks and destroys the stem cells of...

Aims: Alopecia areata is a non-scarring autoimmune disease, quite frequent in the pediatric population. Trichoscopy plays fundamental role its diagnosis, prognosis and therapeutic evaluation. Our objective was to describe trichoscopic signs of alopecia children while showing most population their correlation with disease activity.
 Study Design: Retrospective descriptive study.
 Place...

Mandibulofacial dysostosis, also known as Treacher Collins syndrome, is a rare congenital anomaly that must be identified in infancy to prevent irrevocable developmental impairment. Information is sparse in the current medical literature concerning this rare syndrome. This article reports a case of Treacher Collins syndrome with the presence of a scarring alopecia and acne keloidalis nuchae, wh...

Keratosis follicularis spinulosa decalvans is a rare, X-linked disorder characterized by scarring alopecia of the scalp and eyebrows in the setting of widespread keratosis pilaris. Less frequent associations are ocular abnormalities and palmoplantar keratoderma. Acne keloidalis nuchae has previously been described in one patient with keratosis follicularis spinulosa decalvans. We report another...

Ichthyosis follicular, alopecia, and photophobia (IFAP) syndrome is a rare disease, with possible X-linked mode of inheritance. The patient presented with ocular findings of photophobia, corneal scarring and erosions, superficial and deep corneal vascularization and myopia. He was treated with artificial tears and punctal occlusion with small improvement of photophobia. After three months using...

Tyrosine kinase inhibitors are effective as a target therapy for malignant neoplasms. Imatinib was the first tyrosine kinase inhibitor used. After its introduction, several other drugs have appeared with a similar mechanism of action, but less prone to causing resistance. Even though these drugs are selective, their toxicity does not exclusively target cancer cells, and skin toxicity is the mos...